"Middle Aged" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D008875
|
| MeSH Number(s) |
M01.060.116.630
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Middle Aged".
Below are MeSH descriptors whose meaning is more specific than "Middle Aged".
This graph shows the total number of publications written about "Middle Aged" by people in this website by year, and whether "Middle Aged" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 222 | 222 |
| 1997 | 0 | 225 | 225 |
| 1998 | 0 | 254 | 254 |
| 1999 | 0 | 237 | 237 |
| 2000 | 0 | 310 | 310 |
| 2001 | 0 | 300 | 300 |
| 2002 | 0 | 322 | 322 |
| 2003 | 0 | 370 | 370 |
| 2004 | 0 | 376 | 376 |
| 2005 | 0 | 452 | 452 |
| 2006 | 0 | 543 | 543 |
| 2007 | 0 | 537 | 537 |
| 2008 | 0 | 641 | 641 |
| 2009 | 0 | 588 | 588 |
| 2010 | 0 | 660 | 660 |
| 2011 | 0 | 755 | 755 |
| 2012 | 0 | 782 | 782 |
| 2013 | 0 | 816 | 816 |
| 2014 | 0 | 865 | 865 |
| 2015 | 0 | 912 | 912 |
| 2016 | 0 | 959 | 959 |
| 2017 | 0 | 981 | 981 |
| 2018 | 0 | 1084 | 1084 |
| 2019 | 0 | 1168 | 1168 |
| 2020 | 0 | 989 | 989 |
| 2021 | 0 | 754 | 754 |
| 2022 | 0 | 195 | 195 |
| 2023 | 0 | 300 | 300 |
| 2024 | 0 | 1086 | 1086 |
| 2025 | 0 | 1190 | 1190 |
| 2026 | 0 | 590 | 590 |
To return to the timeline,
click here.
Below are the most recent publications written about "Middle Aged" by people in Profiles.
-
What is the Rate of Occult Vessel Abnormalities in High-Energy Tibial Plateau Fractures (OTA/AO 41)? J Orthop Trauma. 2026 Oct 01; 40(10):555-560.
-
Palopegteriparatide for adults with chronic hypoparathyroidism: skeletal dynamics through 3 years of the phase 2 PaTH forward trial. J Bone Miner Res. 2026 Sep 24; 41(10):1069-1079.
-
Late cytopenia after CD19 chimeric antigen receptor T-cell therapy in large B-cell lymphoma: a Cell Therapy Consortium analysis. Blood Adv. 2026 09 22; 10(18):6188-6197.
-
Characterizing intradural spinal metastasis in the metastatic cascade: clinical course, dissemination timing, and molecular features in 69 patients. J Neurooncol. 2026 Sep 18; 179(3).
-
Long-term patient-reported outcomes and toxicity following salvage radiotherapy for biochemical recurrence after radical prostatectomy. Cancer. 2026 Sep 15; 132(18):e70609.
-
Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC. Nat Med. 2026 Sep; 32(9):3235-3247.
-
Comprehensive Diagnostic Evaluation and Risk of Recurrent Stroke After Embolic Stroke of Undetermined Source: Introducing the Concept of ESUS 2.0. J Am Heart Assoc. 2026 Sep 15; 15(18):e050182.
-
Outcomes of immunocompromised and non-immunocompromised patients in the ICU diverge late in the pandemic. PLoS One. 2026; 21(9):e0357181.
-
The influence of HLA matching on graft survival in lung transplant recipients is indication specific: a UNOS database analysis. Eur Respir J. 2026 Sep; 68(3).
-
Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma. Blood Adv. 2026 09 08; 10(17):5778-5788.